Member of Lyonbiopole
Orixha’s mission is to develop Liquid Ventilation Medical Devices to save lives in Critical Care.
Orixha is developing the Vent2Cool medical device to almost immediately protect the vitals organs, in particular the brain and heart, of patients resuscitated after cardiac arrest and thus significantly reduce mortality and morbidity. Vent2Cool turns the lungs into a heat exchanger with the blood compartment. This makes it possible to induce ultra-rapid therapeutic hypothermia in minutes where current hypothermia solutions take hours to reach the target temperature of 33°C.
Application market: Cardiology, Intensive care medicine, Pneumology - Respiratory Diseases
Type of activity: Medical device
Technologies: Disposable & Implants
Created on may 31st, 2018 - 8 employees
Address
24 rue Laure Diebold 69009 Lyon
You must be logged in and a member of Lyonbiopôle to see the contacts.
